Bortezomib Abolishes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via a p21-Dependent Mechanism in Human Bladder and Prostate Cancer Cells
Laura M. Lashinger(The University of Texas at Austin), David J. McConkey(Johns Hopkins University)
Cited by 109
Related Papers
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Bortezomib Sensitizes Pancreatic Cancer Cells to Endoplasmic Reticulum Stress-Mediated Apoptosis
|Cancer Research|2005|307
Aggresome Disruption: A Novel Strategy to Enhance Bortezomib-Induced Apoptosis in Pancreatic Cancer Cells
|Cancer Research|2006|242
Control of HIF-1α Expression by eIF2α Phosphorylation–Mediated Translational Repression
|Cancer Research|2009|53